GLP-1 stimulates glucose-dependent insulin secretion and suppresses glucagon release, helping lower blood sugar, slows gastric emptying, and promotes satiety
This Journal Club focuses on the SELECT Trial Table of contents for the The SELECT Trial summary: Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes A
a more favorable option for some patients Side Effects: Black Box Warning: RISK OF THYROID C-CELL TUMORS Reference: rxlist.com (Tanzeum) Dulaglutide Drug Name: Trulicity (FDA Approved 9/18/14) GLP-1 receptor agonist, hypoglycemic Pharmacokinetics: Long acting (half life: 5 days) subcutaneous pen injections weekly dosing (vs daily dosing for some other GLP-1 agonists such as exenatide, liraglutide & lixisenatide) a more favorable dosing option for some patients Side Effects: Black Box Warning: RISK OF THYROID C-CELL TUMORS References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)
We use low-and-slow titration , hydration/electrolytes, fiber/protein timing, and meal-size adjustments
Apres son interdiction au Cameroun oriental le 13 Juillet 1955, lUPC va continuer mener son action dans le Cameroun mridional prcisment dans les zones de Tombel et Kumba
